Find News

Filter articles

Applied Filters

Showing 31 to 40 of 225 results

Thailand suspends medical marijuana patents


Thailand’s government has suspended all patents for medical marijuana products, a little more than a month after the country’s parliament voted to approve marijuana for medical use and research.

Indian committee advocates compulsory licensing and price caps


Indian pharmaceutical companies should be encouraged to grant compulsory licences and prices of some patented medicines should be capped, an Indian government panel has said.

Gilead announces licence and collaboration deal with Yuhan

South Korea, US10-01-2019

Gilead Sciences, a biopharmaceutical company based in the US, has entered into a licensing and collaboration agreement with South Korean healthcare company Yuhan.

Indian Supreme Court reinstates Monsanto GM cotton seed patent


The Supreme Court of India has ruled that biotechnology company Monsanto’s patent for genetically modified cotton seeds is valid and enforceable in the country.

United Therapeutics signs 3D bioprinting technology deal

Israel, US23-10-2018

Maryland-based United Therapeutics has inked a licence, development and commercialisation agreement with CollPlant, an Israeli biotech company, for 3D bioprinted lung transplants.

Novartis signs deal to bring CAR T therapy to China


Novartis has teamed up with a clinical-stage biopharmaceutical firm in efforts to bring the Swiss company’s proprietary cancer treatment to patients in China.

Bombay court finds company liable for infringing Glenmark TM


The Bombay High Court has imposed Rs 1.5 crore of costs on a pharmaceutical company which infringed India-based Glenmark Pharmaceuticals’ trademarks.

Chinese individuals indicted for stealing US rice technology

China, US07-08-2018

Two Chinese nationals have been charged with conspiracy to steal rice technology from a US-based biotechnology company.

Almirall to acquire Allergan dermatology portfolio

Spain, US06-08-2018Mergers & acquisitions

Spain-based pharmaceutical company Almirall will acquire Allergan’s dermatology portfolio.

AbbVie faces hepatitis C patent challenge in India


In India, a non-profit organisation and an advocacy group have united to take on a patent covering pibrentasvir, part of the drug combination that forms AbbVie’s hepatitis C product Mavyret.

Showing 31 to 40 of 225 results